PUREMEDICAL ApS: Financial statements 2024
CVR: 31278996
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
PUREMEDICAL ApS (CVR 31278996) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -3,750 and a net result of DKK 484,264 compared with DKK 192,343 the year before. Equity in the 2024 report amounted to DKK 1,722,793. The solvency ratio was 98.8%.
- Gross Profit
- DKK -3,750
- Profit/Loss
- DKK 484,264
- Equity
- DKK 1,722,793
- Total Assets
- DKK 1,744,033
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -4K | 484K | 1.7M | 0 |
| 2023 | - | -4K | 192K | 1.3M | 0 |
| 2022 | - | -4K | 437K | 968K | 0 |
| 2021 | - | -4K | 533K | 531K | 0 |
| 2020 | - | -5K | -262K | -2K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout PUREMEDICAL ApS
PUREMEDICAL ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2008. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named BOAS PLUS ApS and THOMAS BOAS HOLDING ApS. The management consists of Thomas Boas. The company is owned by Thomas Boas. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 470,908 and a net result of DKK 620,918 compared with DKK 819,115 the year before. Equity in the 2026 report amounted to DKK 2,827,747.
